Telix Pharmaceuticals (TLX) Invested Capital (2023 - 2025)
Telix Pharmaceuticals (TLX) posted Invested Capital of $405.0 million for Q4 2025, down 45.63% on a QoQ basis from $744.9 million in Q4 2024, and down 45.63% year-over-year from $744.9 million in Q4 2024.
Telix Pharmaceuticals (TLX) has 3 years of Invested Capital data on file, last reported at $405.0 million in Q4 2025.
- In Q4 2025, Invested Capital fell 45.63% year-over-year to $405.0 million; the TTM figure through Dec 2024 stood at $744.9 million (up 587.81% YoY), while the FY2025 annual figure was $405.0 million, down 45.63% from the prior year.
- Invested Capital fell to $405.0 million in Q4 2025, from $744.9 million in the prior quarter.
- Across five years, Invested Capital topped out at $744.9 million in Q4 2024 and bottomed at $108.3 million in Q4 2023.
- A 3-year average of $419.4 million and a median of $405.0 million in 2025 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2024 — Invested Capital surged 587.81% — and 2025, when it sank 45.63%.
- Year by year, Invested Capital stood at $108.3 million in 2023, then surged by 587.81% to $744.9 million in 2024, then sank by 45.63% to $405.0 million in 2025.
- The last three Invested Capital figures came in at $405.0 million (Q4 2025), $744.9 million (Q4 2024), and $108.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Telix Pharmaceuticals | 4.52 Bn | 4.38 Bn | - | 405.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 405.02 Mn |
| Dec 31, 2024 | 744.87 Mn |
| Dec 31, 2023 | 108.30 Mn |